Abstract:Objective: Disorders of bone homeostasis are the key factors leading to metabolic bone disease, such as senile osteoporosis, which is characterized by age-related bone loss. Bone marrow stromal cells (BMSCs) possess high osteogenic capacity which has been regarded as a practical approach to preventing bone loss. Previous studies have shown that the osteogenic differentiation ability of BMSCs is significantly decreased in senile osteoporosis. Recently, circular RNAs (circRNAs) have been regarded as critical regulators in controlling the osteogenic differentiation of BMSCs by sponging microRNAs (miRNAs). Our study aimed to discover new and critical osteogenesis-related circRNAs that can promote bone formation in senile osteoporosis. Methods: We detected the dysregulated circRNAs of BMSCs upon osteogenic differentiation induction and identified the critical osteogenic circRNA (circ-3626). The relationship between circ-3626 and osteoporosis was further verified in clinical bone samples and aged mice by qPCR. Moreover, circ-3626 AAV was constructed to examine the osteogenic effect of circ-3626 on bone formation via using Micro-CT, double calcein labeling, and the three-point bending tests. Bioinformatics analysis, Luciferase report gene assays, FISH, RNA pull‐down, qPCR, Western Blots, and alizarin red staining assay explore the effects and mechanisms of circ-3626 on osteogenic differentiation of BMSCs. Results: Circ-3626 was identified as a pivotal osteogenesis-related circRNA via RNA sequencing. The results of alizarin red staining, Western blots, and qPCR assays suggest that overexpressing circ-3626 dramatically accelerates the osteogenic capability of BMSCs. Furthermore, the bone repair capability of aging mice could be significantly improved by circ-3626 AAV treatment. Micro RNA miR-338-3p was identified as the downstream target of circ-3626. Overexpression of circ-3626 increases the expression of Runx2 by sponging miR-338-3p, thereby promoting the osteogenic differentiation of BMSCs by upregulating the expression of osteogenic genes. In addition, Western blots, and qPCR assays suggest circ-3626 AAV treatment promote the expression of Runx2 and osteogenic marker genes. Conclusion: Thus, we demonstrate that circ-3626 plays a pivotal role in promoting bone formation through the miR-338-3p/Runx2 axis and may provide new strategies for preventing and treating the bone loss of senile osteoporosis.

CTD-2555A7.2 Promotes Bone Formation with LncRNA-specific Cascade Amplification Strategy

A potential therapeutic drug for osteoporosis: prospect for osteogenic LncRNAs

Silencing Of Lncrna Ak045490 Promotes Osteoblast Differentiation And Bone Formation Via Beta-Catenin/Tcf1/Runx2 Signaling Axis

Long noncoding RNA AK039312 and AK079370 inhibits bone formation via miR-199b-5p

A novel long noncoding RNA AK016739 inhibits osteoblast differentiation and bone formation

Long noncoding RNA Lnc-DIF inhibits bone formation by sequestering miR-489-3p

Network regulatory mechanism of ncRNA on the Wnt signaling pathway in osteoporosis

Long non-coding RNAs in bone formation: Key regulators and therapeutic prospects

Advances of long non-coding RNAs in osteoclast differentiation and osteoporosis

ALX1-transcribed LncRNA AC132217.4 Promotes Osteogenesis and Bone Healing Via IGF-AKT Signaling in Mesenchymal Stem Cells

Noncoding RNA miR‐205‐5p mediates osteoporosis pathogenesis and osteoblast differentiation by regulating RUNX2

Lncrna Expression Profiles and the Negative Regulation of Lncrna-Nommut037835.2 in Osteoclastogenesis.

Silencing long noncoding RNA colon cancer-associated transcript-1 upregulates microRNA-34a-5p to promote proliferation and differentiation of osteoblasts in osteoporosis

LncRNA AK077216 promotes RANKL‐induced osteoclastogenesis and bone resorption via NFATc1 by inhibition of NIP45

Circular RNA circ-3626 promotes bone formation by modulating the miR-338-3p/Runx2 axis

The Long Non-coding RNA-ORLNC1 Regulates Bone Mass by Directing Mesenchymal Stem Cell Fate

MiR-12200-5p Targets Multiple Members of Wnt Signaling Pathway to Inhibit Osteoblast Differentiation and Bone Formation

CircRNAs and LncRNAs in Osteoporosis

LncRNA DANCR and miR-320a suppressed osteogenic differentiation in osteoporosis by directly inhibiting the Wnt/β-catenin signaling pathway

LncRNA TCONS_00023297 Regulates the Balance of Osteogenic and Adipogenic Differentiation in Bone Marrow Mesenchymal Stem Cells and the Coupling Process of Osteogenesis and Angiogenesis

Long non-coding RNAs in osteoporosis: from mechanisms of action to therapeutic potential